Adherence to a well-defined quality system should ensure that all pharmacovigilance activities are conducted in such a way that they are likely to produce the desired results or quality objectives for the fulfilment of pharmacovigilance tasks.
Recital 6, Commission Implementing Regulation (EU) No 520/2012 of 19 June 2012 on the performance o…
In forcesince 31 Dec 2020